Physician profile
Eric M Pitts
NPI 1285757666
$3,996.93
in general payments reported to CMS, 2019-2025
43 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $185 · 2021: $598 · 2022: $624 · 2023: $823 · 2024: $682 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,027.54 |
| Education | $122.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,049.78 | 2021-2025 | |
| Emd Serono, INC. | $371.49 | 2020-2025 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $269.07 | 2019-2025 | |
| Ucb, INC. | $246.80 | 2019-2025 | Nayzilam, Rystiggo, Fintepla |
| Mdd US Operations, LLC | $206.72 | 2019-2024 | Gocovri, Gocovri |
| Sunovion Pharmaceuticals INC. | $158.09 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $147.94 | 2020-2024 | Ultomiris |
| Biogen, INC. | $146.22 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Pfizer INC. | $112.12 | 2022-2025 | |
| Allergan, INC. | $110.57 | 2019-2022 | |
| Horizon Therapeutics Plc | $97.91 | 2022-2023 | Uplizna |
| Amgen INC. | $68.57 | 2021-2025 | Uplizna |
| Catalyst Pharmaceuticals, INC. | $62.66 | 2023-2024 | Fycompa, Firdapse |
| Lundbeck LLC | $60.11 | 2021-2024 | Vyepti |
| Lilly USA, LLC | $58.80 | 2019-2023 | Emgality, Reyvow |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.